The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering

Biomaterials

Volumn 30, Issue 20, 2009, Pages 3415-3427

  Pytlík, Robert ^a   Stehlík, David ^a   Soukup, Tomáš ^a   Kalbáčová, Marie ^b   Rypáček, František ^c   Trč, Tomáš ^a   Mulinková, Katarína ^c   Michnová, Petra ^a   Kideryová, Linda ^a   Živný, Jan ^a   Klener Jr , Pavel ^a   Veselá, Romana ^a   Trněný, Marek ^a   Klener, Pavel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^c INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Czech Republic)

Author keywords

Differentiation; Expansion; Human serum; Multipotent mesenchymal stromal cells; Orthopedic surgery; Tissue engineering

Indexed keywords

ADHERENT CELLS; ADIPOGENIC; ASCORBIC ACIDS; BONE TISSUE ENGINEERINGS; CHONDROGENIC DIFFERENTIATIONS; CLINICAL APPLICATIONS; CO-CULTURE SYSTEMS; CULTIVATION TIME; CYTOKINES; DEXAMETHASONE; DIFFERENTIATION; FETAL CALF SERUMS; GOOD MANUFACTURING PRACTICES; HEMATOPOIETIC CELLS; HUMAN SERUM; IN-VITRO; MINERALIZED TISSUES; MULTIPOTENT MESENCHYMAL STROMAL CELLS; ORTHOPEDIC SURGERY; OSTEOGENIC; POLYLACTIDE; PROTEIN-FREE;

BODY FLUIDS; BONE; CELL CULTURE; CELL MEMBRANES; KETONES; ORGANIC ACIDS; ORTHOPEDICS; SODIUM COMPOUNDS; SURGERY;

TISSUE ENGINEERING;

ASCORBIC ACID; DEXAMETHASONE; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT CYTOKINE; RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 2; RECOMBINANT HUMAN INSULIN; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG;

ADHERENT CELL; ADIPOGENESIS; ADULT; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; BONE TISSUE; CELL DIFFERENTIATION; CHONDROGENESIS; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; FETAL CALF SERUM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNE DEFICIENCY; IN VITRO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; STEM CELL EXPANSION; STROMA CELL; TISSUE ENGINEERING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BONE AND BONES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MIDDLE AGED; MULTIPOTENT STEM CELLS; STROMAL CELLS; TISSUE ENGINEERING; YOUNG ADULT;

MUS;

EID: 67349188907     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.03.001     Document Type: Article

References (54)

1. Connoly J.F., Guse R., Tiedeman J., and Dehne R. Autologous marrow injection for delayed unions of the tibia: a preliminary report. J Orthop Trauma 3 (1989) 276-282
2. Tidemark J., Blomfert R., Ponzer S., Soderquist A., and Tornkvist H. Primary total hip arthroplasty with a Burch-Schneider antiprotrusion cage and autologous bone grafting for acetabular fractures in elderly patients. J Orthop Trauma 17 (2003) 193-197
3. Hernigou P., Poignard A., Beaujean F., and Rouard H. Percutaneous autologous bone-marrow grafting for nonunions: influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87 (2005) 1430-1437
4. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., and Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4 (1998) 415-428
5. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
6. Zhao R.L., Duan W.M., Reyes M., Keene C.D., Verfaillie C.M., and Low W.C. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174 (2002) 11-20
7. Chen L.B., Jiang X.B., and Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10 (2004) 3016-3020
8. Haynesworth S.E., Goshima J., Goldberg V.M., and Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 12 (1992) 81-88
9. Jaiswal N., Haynesworth S.E., Caplan A.I., and Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64 (1997) 295-312
10. Koc O.N., Gerson S.L., Cooper B.W., Dyhouse S.M., Haynesworth S.E., Caplan A.I., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
11. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441
12. Koc O.N., Daj J., Nieder M., Gerson S.L., Lazarus H.M., and Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MDL) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30 (2002) 215-222
13. Kawate K., Yajima H., Ohgushi H., Kotobuki N., SLugimoto K., Ohmura T., et al. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula. Artif Organs 30 (2006) 960-962
14. Bang O.Y., Lee J.S., Lee P.H., and Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57 (2005) 874-882
15. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
16. Wang Z., Wang S., Marois Y., Guidoin R., and Zhang Z. Evaluation of biodegradable synthetic scaffold coated on arterial prostheses implanted in rat subcutaneous tissue. Biomaterials 26 (2005) 7387-7401
17. Sato M., Maeda M., Kurosawa H., Inoue Y., Yamauchi Y., and Iwase H. Reconstruction of rabbit Achilles tendon with three bioabsorbable materials: histological and biomechanical studies. J Orthop Sci 5 (2000) 256-267
18. Ma Z., Gao C., Gong Y., and Shen J. Paraffin spheres as porogen to fabricate poly(l-lactic acid) scaffolds with improved cytocompatibility for cartilage tissue engineering. J Biomed Mater Res B Appl Biomater 67 (2003) 610-617
19. Lin Y.M., Boccaccini A.R., Polak J.M., Bishop A.E., and Maguet V. Biocompatibility of poly-dl-lactic acid (PDLLA) for lung tissue engineering. J Biomater Appl 21 (2006) 109-118
20. Yang F., Xu C.Y., Kotaki M., Wang S., and Ramakrishna S. Characterization of neural stem cells on electrospun poly(l-lactic acid) nanofibrous scaffold. J Biomater Sci Polym Ed 15 (2004) 1483-1497
21. Yao J., Radin S., Reilly G., Leboy P.S., and Ducheyne P. Solution-mediated effect of bioactive glass in poly(lactic-co-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells. J Biomed Mater Res A 75 (2005) 794-801
22. Wang H., Li Y., Zuo Y., Li J., Ma S., and Cheng L. Biocompatibility and osteogenesis of biomimetic nano-hydroxyapatite/polyamide composite scaffolds for bone tissue engineering. Biomaterials 28 (2007) 3338-3348
23. Manello F., and Tonti G.A. Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum or enriched plasma; serum replacement nonconditioned medium or ad hoc formula? All that glitters is not gold!. Stem Cells 25 (2007) 1603-1609
24. Selvaggi T.A., Walker R.E., and Fleisher T.A. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89 (1997) 776-779
25. Dennis J.E., Esterly K., Awadallah A., Parrish C.R., Pohynter G.M., and Goltry K.L. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem Cells 25 (2007) 2575-2582
26. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., and Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107 (1999) 275-281
27. Sugiura F., Kitoh H., and Ischiguro N. Osteogenic potential of rat mesenchymal stem cells after several passages. Biochem Biophys Res Commun 316 (2004) 233-239
28. Gronthos S., and Simmons P.J. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85 (1995) 929-940
29. Jin-Xiang F., Xiaofeng S., Jun-Chuan Q., Yan G., and Xue-Guang Z. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro. Exp Hematol 32 (2004) 1204-1211
30. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., et al. Retention of multilineage differentiation potential of mesencyhmal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288 (2001) 413-419
31. Halme D.G., and Kessler D.A. FDA regulation of stem-cell-based therapies. N Engl J Med 355 (2006) 1730-1735
32. Colter D.C., Class R., DiGirolamo C.M., and Prockop D.J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A 97 (2000) 3213-3218
33. Kubies D., Rypacek F., Kovarova J., and Lednicky F. Microdomain structure in polylactide-block poly(ethylene oxide) copolymer films. Biomaterials 21 (2000) 529-536
34. Gronthos S., Graves S.E., Ohta S., and Simmons P.J. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84 (1994) 4164-4173
35. Haynesworth S.E., Baber M.A., and Caplan A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13 (1992) 69-80
36. Pytlik R., Purkrabkova T., Stehlik D., Hofman P., and Cervinkova P. Growth and differentiation of mesenchymal stem cells in human sera. Bone Marrow Transplant 35 S2 (2005) S77-S78
37. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., et al. PDGF, TGF-b and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSC into adipogenic, chondrogenic and osteogenic lineages. Blood 112 (2008) 295-307
38. Spees J.L., Gregory C.A., Singh H., Tucker H.A., Peister A., Lynch P.J., et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9 (2004) 747-756
39. Berger M.G., Veyrat-Masson R., Rapatel C., Descamps S., Chassagne J., and Boiret-Dupre N. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 24 (2006) 2888-2890
40. Martin M.J., Muotri A., Gage F., and Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 11 2 (2005 Feb) 228-232
41. Heiskanen A., Satomaa T., Tiitinen S., Laitinen A., Mannelin S., Impola U., et al. N-Glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25 (2007) 197-202
42. Kubler D., Gosenca D., Wind M., Heid H., Friedberg I., Jahnen-Dechent W., et al. Proteolytic processing by matrix metalloproteinases and phosphorylation by protein kinase CK2 of fetuin-A, the major globulin of fetal calf serum. Biochimie 89 (2007) 410-418
43. Stute N., Holtz K., Bubenheim M., Lange C., Blake F., and Zander A.R. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32 (2004) 1212-1225
44. Hankey D.P., McCabe R.E., Doherty M.J., Nolan P.C., McAlinden M.G., Nelson J., et al. Enhancement of human osteoblast proliferation and phenotypic expression when cultured in human serum. Acta Orthop Scand 72 (2001) 395-403
45. Schecroun N., and Delloye C. In vitro growth and osteoblastic differentiation of human bone marrow stromal cells supported by autologous plasma. Bone 35 (2004) 517-524
46. Shahdadfar A., Fronsdal K., Haug T., Reinholt F.P., and Brinchmann J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23 (2005) 1357-1366
47. Gregory C.A., Reyes E., Whitney M.J., and Spees J.L. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs. Stem Cells 24 (2006) 2232-2243
48. Kuznetsov S.A., Mankani M.H., and Robey P.G. Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation 70 (2000) 1780-1787
49. Yamaguchi M., Hirayama F., Wakamoto S., Fujihara M., Murahashi H., Sato N., et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion 42 (2002) 921-927
50. Schallmoser K., Bartmann C., Rohde E., Reinisch A., Kashofer K., Stadelmeyer E., et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47 (2007) 1436-1446
51. Baksh D., Davies J.E., and Zandstra P.W. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 31 (2003) 723-732
52. Baksh D., Davies J.E., and Zandstra P.W. Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood 106 (2005) 3012-3019
53. Montjovent M.O., Mark S., Mathieu L., Scaletta C., Scherberich A., Delabarde C., et al. Human fetal bone cells associated with ceramic reinforced PLA scaffolds for tissue engineering. Bone 42 (2008) 554-564
54. Humphries J.D., Byron A., and Humphries M.J. Integrin ligands at a glance. J Cell Sci 119 (2006) 3901-3903